Stocktoria
PHIBRO ANIMAL HEALTH CORP PAHC
Nasdaq · XNAS · stock · Pharmaceutical Preparations · website · IPO 2014-04-11
PHIBRO ANIMAL HEALTH CORP statistics & valuation
Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else is from filings.
Key ratios (by fiscal year)
| Ratio | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Gross margin | 30.9% | 30.8% | 30.5% | 30.3% | 32.6% |
| Operating margin | 8.5% | 5.2% | 7.3% | 8.4% | 9.0% |
| Net margin | 3.7% | 0.2% | 3.3% | 5.2% | 6.5% |
| Return on assets | 3.5% | 0.2% | 3.4% | 5.3% | 6.5% |
| Return on equity | 16.9% | 0.9% | 11.5% | 18.7% | 22.8% |
| Debt / equity | 2.21× | 1.22× | 1.18× | 1.10× | — |
| Current ratio | 2.76 | 2.94 | 3.33 | 2.97 | 3.04 |
| Revenue growth | 27.4% | 4.1% | 3.8% | 13.1% | 4.1% |
Source: SEC EDGAR filings · CIK 0001069899 · as of 2025-06-30. Facts from filings plus Stocktoria's own computed scores — not investment advice.